NCT01472497View on ClinicalTrials.gov

Effects of Pioglitazone in Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2012

Conditions
HypertensionInsulin Resistance
Interventions
DRUG

Pioglitazone

pioglitazone (15mg) once a day for 24 weeks

Trial Locations (1)

683-8504

Tottori University Hospital, Yonago

All Listed Sponsors
lead

Tottori University Hospital

OTHER

NCT01472497 - Effects of Pioglitazone in Hypertensive Patients | Biotech Hunter | Biotech Hunter